Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen Screening

Jonathan Gelfond, Ian M. Thompson, Kara Choate et al.|The Journal of Urology|2015

Cited by 33